UniProt ID | S38A2_HUMAN | |
---|---|---|
UniProt AC | Q96QD8 | |
Protein Name | Sodium-coupled neutral amino acid transporter 2 | |
Gene Name | SLC38A2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 506 | |
Subcellular Localization |
Cell membrane Multi-pass membrane protein . Insulin promotes recruitment to the plasma membrane from a pool localized in the trans-Golgi network or endosomes (By similarity). Enriched in the somatodendritic compartment of neurons, it is also detect |
|
Protein Description | Functions as a sodium-dependent amino acid transporter. Mediates the saturable, pH-sensitive and electrogenic cotransport of neutral amino acids and sodium ions with a stoichiometry of 1:1. May function in the transport of amino acids at the blood-brain barrier and in the supply of maternal nutrients to the fetus through the placenta.. | |
Protein Sequence | MKKAEMGRFSISPDEDSSSYSSNSDFNYSYPTKQAALKSHYADVDPENQNFLLESNLGKKKYETEFHPGTTSFGMSVFNLSNAIVGSGILGLSYAMANTGIALFIILLTFVSIFSLYSVHLLLKTANEGGSLLYEQLGYKAFGLVGKLAASGSITMQNIGAMSSYLFIVKYELPLVIQALTNIEDKTGLWYLNGNYLVLLVSLVVILPLSLFRNLGYLGYTSGLSLLCMVFFLIVVICKKFQVPCPVEAALIINETINTTLTQPTALVPALSHNVTENDSCRPHYFIFNSQTVYAVPILIFSFVCHPAVLPIYEELKDRSRRRMMNVSKISFFAMFLMYLLAALFGYLTFYEHVESELLHTYSSILGTDILLLIVRLAVLMAVTLTVPVVIFPIRSSVTHLLCASKDFSWWRHSLITVSILAFTNLLVIFVPTIRDIFGFIGASAASMLIFILPSAFYIKLVKKEPMKSVQKIGALFFLLSGVLVMTGSMALIVLDWVHNAPGGGH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Ubiquitination | ------MKKAEMGRF ------CCCCCCCCC | 61.77 | - | |
3 | Ubiquitination | -----MKKAEMGRFS -----CCCCCCCCCC | 48.56 | - | |
3 (in isoform 1) | Ubiquitination | - | 48.56 | 21890473 | |
10 | Phosphorylation | KAEMGRFSISPDEDS CCCCCCCCCCCCCCC | 22.31 | 21945579 | |
12 | Phosphorylation | EMGRFSISPDEDSSS CCCCCCCCCCCCCCC | 25.71 | 23401153 | |
17 | Phosphorylation | SISPDEDSSSYSSNS CCCCCCCCCCCCCCC | 21.09 | 25463755 | |
18 | Phosphorylation | ISPDEDSSSYSSNSD CCCCCCCCCCCCCCC | 45.69 | 21945579 | |
19 | Phosphorylation | SPDEDSSSYSSNSDF CCCCCCCCCCCCCCC | 32.74 | 21945579 | |
20 | Phosphorylation | PDEDSSSYSSNSDFN CCCCCCCCCCCCCCC | 20.33 | 21945579 | |
21 | Phosphorylation | DEDSSSYSSNSDFNY CCCCCCCCCCCCCCC | 25.62 | 21945579 | |
22 | Phosphorylation | EDSSSYSSNSDFNYS CCCCCCCCCCCCCCC | 31.92 | 21945579 | |
24 | Phosphorylation | SSSYSSNSDFNYSYP CCCCCCCCCCCCCCC | 45.59 | 21945579 | |
28 | Phosphorylation | SSNSDFNYSYPTKQA CCCCCCCCCCCCHHH | 15.02 | 21945579 | |
29 | Phosphorylation | SNSDFNYSYPTKQAA CCCCCCCCCCCHHHH | 26.24 | 21945579 | |
30 | Phosphorylation | NSDFNYSYPTKQAAL CCCCCCCCCCHHHHH | 12.45 | 21945579 | |
32 | Phosphorylation | DFNYSYPTKQAALKS CCCCCCCCHHHHHHH | 27.79 | 21945579 | |
33 (in isoform 1) | Ubiquitination | - | 33.17 | 21890473 | |
33 | Ubiquitination | FNYSYPTKQAALKSH CCCCCCCHHHHHHHC | 33.17 | 21890473 | |
38 | Ubiquitination | PTKQAALKSHYADVD CCHHHHHHHCCCCCC | 30.38 | 21890473 | |
38 | Methylation | PTKQAALKSHYADVD CCHHHHHHHCCCCCC | 30.38 | 24575611 | |
38 (in isoform 1) | Ubiquitination | - | 30.38 | 21890473 | |
39 | Phosphorylation | TKQAALKSHYADVDP CHHHHHHHCCCCCCH | 23.68 | 21945579 | |
40 (in isoform 2) | Ubiquitination | - | 21.88 | 21906983 | |
41 | Phosphorylation | QAALKSHYADVDPEN HHHHHHCCCCCCHHH | 16.16 | 23927012 | |
55 | Phosphorylation | NQNFLLESNLGKKKY HCCCHHHHCCCCCCE | 37.01 | 21945579 | |
59 | Ubiquitination | LLESNLGKKKYETEF HHHHCCCCCCEECCC | 49.62 | 20972266 | |
59 (in isoform 1) | Ubiquitination | - | 49.62 | 21890473 | |
60 | Ubiquitination | LESNLGKKKYETEFH HHHCCCCCCEECCCC | 59.81 | - | |
60 (in isoform 1) | Ubiquitination | - | 59.81 | 21890473 | |
134 | Phosphorylation | NEGGSLLYEQLGYKA CCCCCHHHHCCCCCH | 13.61 | - | |
140 (in isoform 1) | Ubiquitination | - | 35.13 | 21890473 | |
140 | Ubiquitination | LYEQLGYKAFGLVGK HHHCCCCCHHHHHHH | 35.13 | - | |
210 | Phosphorylation | LVVILPLSLFRNLGY HHHHHHHHHHCCCCC | 24.42 | 24719451 | |
217 | Phosphorylation | SLFRNLGYLGYTSGL HHHCCCCCCCHHCHH | 10.50 | - | |
220 | Phosphorylation | RNLGYLGYTSGLSLL CCCCCCCHHCHHHHH | 8.64 | - | |
221 | Phosphorylation | NLGYLGYTSGLSLLC CCCCCCHHCHHHHHH | 17.96 | - | |
258 | N-linked_Glycosylation | LIINETINTTLTQPT EEEECCCCCCCCCCC | 34.14 | UniProtKB CARBOHYD | |
274 | N-linked_Glycosylation | LVPALSHNVTENDSC HHCHHCCCCCCCCCC | 38.74 | UniProtKB CARBOHYD | |
320 | Phosphorylation | YEELKDRSRRRMMNV HHHHHHHHHHHHCCH | 40.03 | 24719451 | |
324 | Sulfoxidation | KDRSRRRMMNVSKIS HHHHHHHHCCHHHHH | 1.86 | 30846556 | |
325 | Sulfoxidation | DRSRRRMMNVSKISF HHHHHHHCCHHHHHH | 4.20 | 30846556 | |
328 | Phosphorylation | RRRMMNVSKISFFAM HHHHCCHHHHHHHHH | 21.19 | 24719451 | |
403 | S-palmitoylation | SSVTHLLCASKDFSW HHHHHHHHHCCCCCH | 5.17 | 29575903 | |
469 | Phosphorylation | VKKEPMKSVQKIGAL HCCCCCCHHHHHHHH | 24.43 | 18669648 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of S38A2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of S38A2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10 AND SER-12, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10; SER-12 AND SER-469,AND MASS SPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-41, AND MASSSPECTROMETRY. | |
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-20 AND TYR-41, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-41, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-41, AND MASSSPECTROMETRY. | |
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules."; Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.; Mol. Cell. Proteomics 4:1240-1250(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-20, AND MASSSPECTROMETRY. |